(Q50881104)

English

Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.

scientific article published in December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

amyotrophic lateral sclerosis

0 references

quality of life

1 reference

based on heuristic

inferred from title

author name string

Imelda J M De Groot

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Marcel W M Post

2

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Tineke van Heuveln

3

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Leonard H Van den Berg

4

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Eline Lindeman

5

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

8

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

6

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

356-361

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Multidisciplinary ALS care improves quality of life in patients with ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Factors supporting quality of life over time for individuals with amyotrophic lateral sclerosis: the role of positive self-perception and religiosity.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

A cross sectional study on determinants of quality of life in ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Quality of Life in Patients with Amyotrophic Lateral Sclerosis: Perceptions, Coping Resources, and Illness Characteristics

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Validation of quality of life instruments in ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Quality of life in ALS depends on factors other than strength and physical function.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Comparison of instruments addressing quality of life in patients with ALS and their caregivers.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Measures and markers in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Effects of the early diagnosis of amyotrophic lateral sclerosis on the patient: disadvantages.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Clinical and epidemiological features of motor neuron disease in south-western Greece

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

A randomized sequential trial of creatine in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Development and validation of a short measure of health status for individuals with amyotrophic lateral sclerosis/motor neurone disease: the ALSAQ-40.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Resilience and distress among amyotrophic lateral sclerosis patients and caregivers

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Prevalence of depressive disorders and change over time in late-stage ALS.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Emotional responding in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Amyotrophic lateral sclerosis and hopelessness: psychosocial factors

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Measuring quality of life: Is quality of life determined by expectations or experience?

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Longitudinal quality of life in advanced cancer patients: pilot study results from a VA medical cancer center.

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Inter-evaluator reliability of the ALS Functional Rating Scale

1 reference

https://api.crossref.org/works/10.1080%2F17482960701553949

21 January 2018

Identifiers

10.1080/17482960701553949

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/18033593

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50881104&oldid=1241972049"